Cotinga Pharmaceuticals Inc. (COT.V) Competitors

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, valuation, profitability, dividends, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Cotinga Pharmaceuticals Inc. (COT.V) and BriaCell Therapeutics, as provided by MarketBeat.com.

Profitability

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and BriaCell Therapeutics' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and BriaCell Therapeutics' gross revenue, earnings per share and valuation.

BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Summary

Cotinga Pharmaceuticals Inc. (COT.V) beats BriaCell Therapeutics on 2 of the 2 factors compared between the two stocks.

Revive Therapeutics (CVE:RVV) and Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Valuation & Earnings

This table compares Revive Therapeutics and Cotinga Pharmaceuticals Inc. (COT.V)'s revenue, earnings per share (EPS) and valuation.

Revive Therapeutics is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Revive Therapeutics and Cotinga Pharmaceuticals Inc. (COT.V), as reported by MarketBeat.

Profitability

This table compares Revive Therapeutics and Cotinga Pharmaceuticals Inc. (COT.V)'s net margins, return on equity and return on assets.

Pacgen Life Science Co. (PBS.V) (CVE:PBS) and Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, valuation, dividends and earnings.

Dividends

Pacgen Life Science Co. (PBS.V) pays an annual dividend of C$0.09 per share and has a dividend yield of 300.0%. Cotinga Pharmaceuticals Inc. (COT.V) pays an annual dividend of C$0.24 per share and has a dividend yield of 685.7%. Pacgen Life Science Co. (PBS.V) pays out -1,500.0% of its earnings in the form of a dividend. Cotinga Pharmaceuticals Inc. (COT.V) pays out -208.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Profitability

This table compares Pacgen Life Science Co. (PBS.V) and Cotinga Pharmaceuticals Inc. (COT.V)'s net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings for Pacgen Life Science Co. (PBS.V) and Cotinga Pharmaceuticals Inc. (COT.V), as provided by MarketBeat.

Valuation & Earnings

This table compares Pacgen Life Science Co. (PBS.V) and Cotinga Pharmaceuticals Inc. (COT.V)'s gross revenue, earnings per share and valuation.

Cotinga Pharmaceuticals Inc. (COT.V) has lower revenue, but higher earnings than Pacgen Life Science Co. (PBS.V). Pacgen Life Science Co. (PBS.V) is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Summary

Pacgen Life Science Co. (PBS.V) beats Cotinga Pharmaceuticals Inc. (COT.V) on 3 of the 5 factors compared between the two stocks.

Medifocus Inc. (MFS.V) (CVE:MFS) and Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Analyst Ratings

This is a breakdown of recent recommendations for Medifocus Inc. (MFS.V) and Cotinga Pharmaceuticals Inc. (COT.V), as provided by MarketBeat.

Profitability

This table compares Medifocus Inc. (MFS.V) and Cotinga Pharmaceuticals Inc. (COT.V)'s net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Medifocus Inc. (MFS.V) and Cotinga Pharmaceuticals Inc. (COT.V)'s gross revenue, earnings per share (EPS) and valuation.

Cotinga Pharmaceuticals Inc. (COT.V) has lower revenue, but higher earnings than Medifocus Inc. (MFS.V). Medifocus Inc. (MFS.V) is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Summary

Medifocus Inc. (MFS.V) beats Cotinga Pharmaceuticals Inc. (COT.V) on 2 of the 3 factors compared between the two stocks.

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Profitability

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and (CHV)'s net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and (CHV)'s gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of current ratings and target prices for Cotinga Pharmaceuticals Inc. (COT.V) and (CHV), as provided by MarketBeat.

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) and (PREV) (CNSX:PREV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Profitability

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and (PREV)'s net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings and target prices for Cotinga Pharmaceuticals Inc. (COT.V) and (PREV), as provided by MarketBeat.

Valuation & Earnings

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and (PREV)'s gross revenue, earnings per share (EPS) and valuation.